Little Green Pharma Ltd (AU:LGP) — Market Cap & Net Worth
Market Cap & Net Worth: Little Green Pharma Ltd (LGP)
Little Green Pharma Ltd (AU:LGP) has a market capitalization of $15.80 Million (AU$22.33 Million) as of September 20, 2026. Listed on the AU stock exchange, this Australia-based company holds position #25926 globally and #1144 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Little Green Pharma Ltd's stock price AU$0.07 by its total outstanding shares 305855910 (305.86 Million). Also see Little Green Pharma Ltd asset portfolio for a full breakdown of the balance sheet.
Little Green Pharma Ltd Market Cap History: 2020 to 2026
Little Green Pharma Ltd's market capitalization history from 2020 to 2026. Data shows change from $122.27 Million to $15.80 Million (-21.19% CAGR). Also see Little Green Pharma Ltd cash conversion from operations for how efficiently the company converts equity into cash flow.
Little Green Pharma Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Little Green Pharma Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check LGP stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.73x
Little Green Pharma Ltd's market cap is 0.73 times its annual revenue
Latest Price to Earnings (P/E) Ratio
8.14x
Little Green Pharma Ltd's market cap is 8.14 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $122.27 Million | $2.20 Million | -$8.28 Million | 55.48x | N/A |
| 2021 | $128.77 Million | $7.00 Million | -$4.36 Million | 18.39x | N/A |
| 2022 | $38.95 Million | $14.04 Million | -$24.07 Million | 2.77x | N/A |
| 2023 | $30.30 Million | $19.57 Million | -$9.21 Million | 1.55x | N/A |
| 2024 | $27.05 Million | $25.63 Million | -$8.15 Million | 1.06x | N/A |
| 2025 | $27.05 Million | $36.82 Million | $3.32 Million | 0.73x | 8.14x |
Competitor Companies of LGP by Market Capitalization
Companies near Little Green Pharma Ltd in the global market cap rankings as of September 20, 2026. Review Little Green Pharma Ltd tangible equity quality to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Little Green Pharma Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #613 globally with a market cap of $44.92 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #635 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #670 globally with a market cap of $40.99 Billion USD ( CN¥280.10 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #613 | GALDERMA GROUP AG | NYSE:GALDY | $44.92 Billion | $38.53 |
| #635 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.90 |
| #670 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $40.99 Billion | CN¥43.91 |
Little Green Pharma Ltd Historical Marketcap From 2020 to 2026
Between 2020 and today, Little Green Pharma Ltd's market cap moved from $122.27 Million to $ 15.80 Million, with a yearly change of -21.19%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$15.80 Million | -41.60% |
| 2025 | AU$27.05 Million | 0.00% |
| 2024 | AU$27.05 Million | -10.71% |
| 2023 | AU$30.30 Million | -22.22% |
| 2022 | AU$38.95 Million | -69.75% |
| 2021 | AU$128.77 Million | +5.31% |
| 2020 | AU$122.27 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of Little Green Pharma Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $15.80 Million USD |
| MoneyControl | $15.80 Million USD |
| MarketWatch | $15.80 Million USD |
| marketcap.company | $15.80 Million USD |
| Reuters | $15.80 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Little Green Pharma Ltd
Little Green Pharma Ltd engages in the cultivation, production, and distribution of medicinal cannabis products in Australia and internationally. The company offers dried cannabis flower medicines and cannabis oils. Little Green Pharma Ltd was incorporated in 2016 and is based in West Perth, Australia.